Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 -44.45M
December 31, 2024 -46.11M
December 31, 2023 -59.06M
December 31, 2022 -60.78M
Date Value
December 31, 2021 -46.35M
December 31, 2020 -20.83M
December 31, 2019 -13.07M
December 31, 2018 -4.651M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Champions Oncology, Inc. -4.472M
Medpace Holdings, Inc. 713.22M
Avantor, Inc. 623.80M
Personalis, Inc. -74.95M
Adaptive Biotechnologies Corp. -45.99M